Lumateperone low dose

DRUG2 trials

Sponsors

Intra-Cellular Therapies, Inc.

Conditions

Irritability Associated With Autism Spectrum Disorder

Phase 3

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

RecruitingNCT06690398

Intra-Cellular Therapies, Inc.Irritability Associated With Autism Spectrum Disorder

Start: 2024-11-22End: 2027-07-19Target: 160Updated: 2026-08-28

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

RecruitingNCT06706674

Intra-Cellular Therapies, Inc.Irritability Associated With Autism Spectrum Disorder

Start: 2024-12-06End: 2027-06-21Target: 160Updated: 2026-08-28